You are cordially invited to an informative seminar on the topic of conducting life sciences research and business in the United States.
The importance of understanding the state level in the U.S. market cannot be overstated. Life sciences activity within U.S. states operates in ecosystems.
At this seminar, you will get a chance to learn about the life sciences ecosystem in the State of Alabama and the cutting-edge precision medicine research being conducted.
This seminar is organized as part of a larger Life Sciences Trade & Investment Mission travelling to Copenhagen in late April 2017.
Date: Friday, April 28, 2017 from 9:30 – 12:30
Place: COBIS, Ole Maaløes Vej 3, 2200 København N
Agenda:
|
9:30 |
Registration, Coffee and Networking |
|
09:45 – 10:00 |
Navigating your Bioscience entry to the U.S. and the State of Life Sciences sector |
|
10:00 – 10:10 |
Science on the Cutting Edge: Informatic and Genomic Precision Medicine Solutions |
|
10:10 – 10:40 |
Clinical Utility of Precision Medicine; Improving Quality and Reducing Costs through |
|
10:40 – 11:00 |
Solving the World’s Hardest Problems Dr. Timothy J. Sellati, Distinguished Fellow and Chair, Department of Infectious Diseases, Drug Discovery Division, Southern Research |
|
11:00 – 11:20 |
Bolstering Biotech Industry via Micro clusters and PPPs |
|
11:20 – 11:50 |
Transformation of Big Data into Clinically Actionable Knowledge; the Precision Medicine |
|
11:50 – 12:00 |
Dialogue with the Presenters – Questions & Answers |
|
12:00 – 12:30 |
Lunch |
|
12:30 |
Conclusion of program |
About the Life Sciences Sector in the State of Alabama
Alabama is home to more than 800 bioscience companies, including 54 medical device companies, with a long list of accolades that accompany them. Birmingham-based Southern Research, for instance, has discovered seven FDA-approved drugs used in cancer treatment and has made important advances in the treatment of AIDS, polio, and mosquito-borne viruses. The HudsonAlpha Institute for Biotechnology in Huntsville is a leader in research on the human genome, gathering genomic data for thousands of academic, clinical, and commercial clients nationwide. Underscoring the track record of innovation found in Alabama’s bioscience sector is the fact that organizations in the state received $280 million in National Institutes of Health (NIH) funding in 2015.
In collaboration with
